MedPath
NMPA Approval

Milnacipran Hydrochloride Tablets

国药准字H20247158

July 10, 2024

国药准字H20100052

Drug Information

盐酸米那普仑片

片剂

50mg

化学药品

July 10, 2024

Company Information

Applicant Company

上海市浦东新区建陆路378号

Manufacturing Company

上海市浦东新区建陆路378号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸米那普仑片 - NMPA 批准文号 | MedPath